Prednisone Withdrawn Phase 2 Trials for Localized Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02159690A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
NCT01087580Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer
NCT00811031Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)
NCT01478308Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer